- Report
- February 2025
- 100 Pages
Global
From €5289EUR$5,950USD£4,581GBP
- Report
- April 2025
- 175 Pages
Global
From €3991EUR$4,490USD£3,457GBP
- Report
- September 2025
- 100 Pages
Global
From €4355EUR$4,900USD£3,773GBP
- Report
- September 2025
- 100 Pages
Global
From €4355EUR$4,900USD£3,773GBP
- Report
- September 2025
- 100 Pages
Global
From €4355EUR$4,900USD£3,773GBP
- Report
- October 2025
- 100 Pages
Global
From €5289EUR$5,950USD£4,581GBP
- Report
- July 2025
- 150 Pages
Global
From €5289EUR$5,950USD£4,581GBP
- Report
- June 2025
- 110 Pages
Global
From €5289EUR$5,950USD£4,581GBP
- Report
- May 2025
- 150 Pages
Global
From €5289EUR$5,950USD£4,581GBP
- Report
- January 2026
- 199 Pages
Global
From €3501EUR$3,939USD£3,033GBP
- Report
- January 2026
- 191 Pages
Global
From €3501EUR$3,939USD£3,033GBP
- Report
- January 2026
- 195 Pages
Global
From €3501EUR$3,939USD£3,033GBP
- Report
- January 2026
- 189 Pages
Global
From €3501EUR$3,939USD£3,033GBP
- Report
- January 2026
- 194 Pages
Global
From €3501EUR$3,939USD£3,033GBP
- Report
- January 2026
- 182 Pages
Global
From €3501EUR$3,939USD£3,033GBP
- Report
- January 2026
- 183 Pages
Global
From €3501EUR$3,939USD£3,033GBP
- Report
- November 2025
- 184 Pages
Global
From €3501EUR$3,939USD£3,033GBP
- Report
- January 2026
- 191 Pages
Global
From €3501EUR$3,939USD£3,033GBP
- Report
- January 2026
- 196 Pages
Global
From €3501EUR$3,939USD£3,033GBP
- Report
- November 2025
- 191 Pages
Global
From €3501EUR$3,939USD£3,033GBP

The Hematological Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat hematological diseases. These diseases include anemia, leukemia, lymphoma, and other blood disorders. Hematological drugs are used to treat a variety of conditions, including cancer, autoimmune diseases, and blood disorders.
The hematological drugs market is composed of a variety of companies, including large pharmaceutical companies, biotechnology companies, and specialty drug companies. These companies develop and produce drugs to treat hematological diseases, as well as other conditions. Some of the major players in the hematological drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more